Technical Analysis for SNPX - Synaptogenix, Inc.

Grade Last Price % Change Price Change
F 0.20 -2.48% -0.01
SNPX closed down 2.48 percent on Monday, March 18, 2024, on 16 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
NR7 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Crossed Above 20 DMA Bullish -2.48%
MACD Bullish Signal Line Cross Bullish -2.48%
Wide Bands Range Expansion -2.48%
Up 3 Days in a Row Strength -2.48%
Wide Bands Range Expansion 9.44%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 9 hours ago
Possible Inside Day about 9 hours ago
60 Minute Opening Range Breakout about 10 hours ago
20 DMA Support about 12 hours ago
Down 3% about 13 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Synaptogenix, Inc. Description

Synaptogenix is a clinical-stage biopharmaceutical company that has historically worked to develop novel therapies for neurodegenerative diseases. Synaptogenix has conducted clinical and preclinical studies of its lead therapeutic candidate, Bryostatin-1, in Alzheimer's disease. Preclinical studies have also demonstrated Bryostatin's regenerative mechanisms of action for the rare disease, Fragile X syndrome, and for other neurodegenerative disorders such as multiple sclerosis, stroke, and traumatic brain injury. The U.S. Food and Drug Administration has granted Orphan Drug Designation to Synaptogenix for Bryostatin-1 as a treatment for Fragile X syndrome. Bryostatin-1 has already undergone testing in more than 1,500 people in cancer studies, thus creating a large safety data base that will further inform clinical trial designs.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Biology Neuroscience Rare Diseases Alzheimer's Disease Stroke Neurodegenerative Diseases Multiple Sclerosis Amyotrophic Lateral Sclerosis Neurodegeneration Neurodegenerative Disorders Fragile X Syndrome Traumatic Brain Injury

Is SNPX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.88
52 Week Low 0.1411
Average Volume 880,084
200-Day Moving Average 0.43
50-Day Moving Average 0.20
20-Day Moving Average 0.20
10-Day Moving Average 0.19
Average True Range 0.03
RSI (14) 50.98
ADX 18.17
+DI 20.92
-DI 14.26
Chandelier Exit (Long, 3 ATRs) 0.21
Chandelier Exit (Short, 3 ATRs) 0.24
Upper Bollinger Bands 0.24
Lower Bollinger Band 0.16
Percent B (%b) 0.52
BandWidth 40.78
MACD Line 0.00
MACD Signal Line -0.01
MACD Histogram 0.0016
Fundamentals Value
Market Cap 4.02 Million
Num Shares 20.4 Million
EPS -0.85
Price-to-Earnings (P/E) Ratio -0.23
Price-to-Sales 0.00
Price-to-Book 0.15
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.21
Resistance 3 (R3) 0.21 0.21 0.21
Resistance 2 (R2) 0.21 0.20 0.21 0.21
Resistance 1 (R1) 0.20 0.20 0.20 0.20 0.21
Pivot Point 0.20 0.20 0.20 0.20 0.20
Support 1 (S1) 0.19 0.19 0.19 0.19 0.19
Support 2 (S2) 0.19 0.19 0.19 0.18
Support 3 (S3) 0.18 0.19 0.18
Support 4 (S4) 0.18